Related references
Note: Only part of the references are listed.Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-α in human osteoarthritic chondrocytes
Seong-Su Nah et al.
FEBS LETTERS (2007)
Activation of receptor for advanced glycation end products in osteoarthritis leads to increased stimulation of chondrocytes and synoviocytes
MMC Steenvoorden et al.
ARTHRITIS AND RHEUMATISM (2006)
Articular chondrocytes express the receptor for advanced glycation end products - Potential role in osteoarthritis
RF Loeser et al.
ARTHRITIS AND RHEUMATISM (2005)
Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis
J DeGroot et al.
ARTHRITIS AND RHEUMATISM (2004)
Changes in the ratio of type-I and type-II collagen expression during monolayer culture of human chondrocytes
S Marlovits et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2004)
Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding
G Sorci et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro
NH Veilleux et al.
TISSUE ENGINEERING (2004)
The receptor for advanced glycation end-products (RAGE) directly binds to ERK by a D-domain-like docking site
K Ishihara et al.
FEBS LETTERS (2003)
Microsomal prostaglandin E synthase-1 is a major terminal synthase that is selectively up-regulated during cyclooxygenase-2-dependent prostaglandin E2 production in the rat adjuvant-induced arthritis model
D Claveau et al.
JOURNAL OF IMMUNOLOGY (2003)
Cellular uptake of beta M-2 and AGE-beta M-2 in synovial fibroblasts and macrophages
KD O'Neill et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Cyclooxygenase-2 and prostaglandins in articular tissues
J Martel-Pelletier et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2003)
Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage
AC Chen et al.
ARTHRITIS AND RHEUMATISM (2002)
Induction of cyclooxygenase-2 by mechanical stress through a nitric oxide-regulated pathway
B Fermor et al.
OSTEOARTHRITIS AND CARTILAGE (2002)
CD36 serves as a receptor for advanced glycation endproducts (AGE)
N Ohgami et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2002)
Age-related accumulation of the advanced glycation endproduct pentosidine in human articular cartilage aggrecan: the use of pentosidine levels as a quantitative measure of protein turnover
N Verzijl et al.
MATRIX BIOLOGY (2001)
Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes
J DeGroot et al.
EXPERIMENTAL CELL RESEARCH (2001)
Requirement for p38 and p44/p42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-κB transcriptional activation and cytokine secretion
CH Yeh et al.
DIABETES (2001)
Effects of nitric oxide on matrix metalloproteinase-2 production by rheumatoid synovial cells
Y Hirai et al.
LIFE SCIENCES (2001)
Effect of collagen turnover on the accumulation of advanced glycation end products
N Verzijl et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2
M Murakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors
DT Felson et al.
ANNALS OF INTERNAL MEDICINE (2000)
Nitric oxide is a mediator of apoptosis in the rheumatoid joint
RJ van't Hof et al.
RHEUMATOLOGY (2000)
Share Paper
